These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Delaware
|
|
94-3290283
|
|
(State
or Other Jurisdiction of Incorporation or
Organization)
|
|
(I.R.S.
Employee Identification No.)
|
|
|
|
|
|
42307 Osgood Road, Suite I
Fremont, California
|
|
94539
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Title
of each class
|
|
Name
of each exchange on which registered
|
|
Class A Common Stock, $0.0001 par value per share
|
|
Nasdaq Global Market
|
|
Large
accelerated
filer
☐
|
Accelerated filer
☐
|
|
Non-accelerated
file
☐
|
Smaller
reporting company ☑
|
|
|
Emerging
growth company ☑
|
|
Class
|
|
Number
of Shares Outstanding
|
|
Class A Common Stock, $0.0001 par value
|
|
14,176,690 shares outstanding as of March 8, 2019
|
|
Class B Common Stock, $0.0001 par value
|
|
1,898,423 shares outstanding as of March 8, 2019
|
|
PART I
|
|||
|
Item 1
|
Business
|
|
3
|
|
Item 1A
|
Risk Factors
|
|
14
|
|
Item 2
|
Properties
|
|
37
|
|
Item 3
|
Legal Proceedings
|
|
38
|
|
PART II
|
|||
|
Item 5
|
Market for Registrant’s Common Equity, Related Stockholder
Matters and
|
|
|
|
|
Issuer Purchases of Equity Securities
|
|
39
|
|
Item 7
|
Management’s Discussion and Analysis of Financial Condition
and Results of Operations
|
|
40
|
|
Item 8
|
Financial Statements and Supplementary Data
|
|
63
|
|
Item 9A
|
Controls and Procedures
|
|
98
|
|
PART III
|
|||
|
Item 10
|
Directors, Executive Officers and Corporate Governance
|
|
99
|
|
Item 11
|
Executive Compensation
|
|
99
|
|
Item 12
|
Security Ownership of Certain Beneficial Owners and Management
and
|
|
|
|
|
Related Stockholder Matters
|
|
99
|
|
Item 13
|
Certain Relationships and Related Transactions, and Director
Independence
|
|
99
|
|
Item 14
|
Principal Accountant Fees and Services
|
|
99
|
|
PART IV
|
|||
|
Item 15
|
Exhibits and Financial Statement Schedules
|
|
100
|
|
Signatures
|
|
|
102
|
|
We
currently offer two principal models of wet wafer cleaning
equipment based on our SAPS technology, Ultra C SAPS II and Ultra C
SAPS V. Each of these models is a single-wafer, serial-processing
tool that can be configured to customer specifications and, in
conjunction with appropriate dilute chemicals, used to remove
random defects from wafer surfaces or interconnects and barrier
metals as part of the chip front-end fabrication process or for
recycling test wafers. By combining our megasonic and chemical
cleaning technologies, we have designed these tools to remove
random defects with greater efficacy and efficiency than
conventional wafer cleaning processes, with enhanced process
flexibility and reduced quantities of chemicals. Each of our SAPS
models was initially built to meet specific requirements of a key
customer. The sales prices of our SAPS tools generally range
between $2.5 million and $5.0 million, although the sales price of
a particular tool will vary depending upon the required
specifications.
|
|
●
compact design,
with footprint of 2.65m x 4.10m x 2.85m (WxDxH), requiring limited
clean room floor space;
●
up
to 8 chambers, providing throughput of up to 225 wafers per
hour;
●
double-sided
cleaning capability, with up to 5 cleaning chemicals for process
flexibility;
●
2-chemical
recycling capability for reduced chemical consumption;
●
image
wafer detection method for lowering wafer breakage rates;
and
●
chemical
delivery module for delivery of dilute hydrofluoric acid, RCA SC-1
solution, functional de-ionized water and carbon dioxide to each of
the chambers.
|
|
●
compact
design, with footprint of 2.55m x 5.1m x 2.85m
(WxDxH);
●
up
to 12 chambers, providing throughput of up to 375 wafers per
hour;
●
chemical
supply system integrated into mainframe;
●
inline
mixing method replaces tank auto-changing, reducing process time;
and
●
improved
drying technology using hot isopropyl alcohol and de-ionized
water.
|
|
|
|
|
TEBO
Technology,
Applications and Equipment
|
|
●
an
equipment front-end module, or EFEM, which moves wafers from
chamber to chamber;
●
one
or more chamber modules, each equipped with a TEBO megasonic
generator system;
●
an
electrical module to provide power for the tool; and
●
a
chemical delivery module.
|
|
● compact
design, with footprint of 2.25m x 2.25m x 2.85m
(WxDxH);
● up to
8 chambers with an upgraded transport system and optimized robotic
scheduler, providing throughput of up to 300 wafers per
hour;
● EFEM
module consisting of 4 load ports, transfer robot and 1 process
robot; and
● focus
on dilute chemicals contributes to environmental sustainability and
lower cost of ownership.
|
|
● footprint
of 2.45m x 5.30m x 2.85m (WxDxH);
● up to
12 chamber modules, providing throughput of up to 300 wafers per
hour;
● EFEM
module consisting of 4 load ports, 1 transfer robot and
1 process robot; and
● chemical
delivery module for delivery of isopropyl alcohol, dilute
hydrofluoric acid, RCA SC-1 solution, functional de-ionized water
and carbon dioxide to each of the chambers.
|
|
For
example, our Ultra C Coater is used in applying photoresist, a
light-sensitive material used in photolithography to transfer a
pattern from a mask onto a wafer. Coaters typically provide input
and output elevators, shuttle systems and other devices to handle
and transport wafers during the coating process. Unlike most
coaters, the Ultra C Coater is fully automated. Based on requests
from customers, we developed and incorporated the special function
of chamber auto-clean module into the Ultra C Coater, which further
differentiates it from other products in the market. The Ultra C
Coater is designed to deliver improved throughput and more
efficient tool utilization while eliminating particle
generation.
|
|
|
Year Ended
December 31,
|
|
|
|
2018
|
2017
|
|
|
(in
thousands)
|
|
|
Stock-Based
Compensation Expense:
|
|
|
|
Cost of
revenue
|
$
71
|
$
21
|
|
Sales and marketing
expense
|
120
|
53
|
|
Research and
development expense
|
255
|
50
|
|
General and
administrative expense
|
2,917
|
1,499
|
|
|
$
3,363
|
$
1,623
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
|
(in
thousands)
|
|
|
Adjusted EBITDA Data:
|
|
|
|
Net
income (loss) attributable to ACM Research, Inc.
|
$
6,574
|
$
(318
)
|
|
Interest
expense, net
|
469
|
268
|
|
Income
tax expense
|
806
|
547
|
|
Depreciation
and amortization
|
417
|
271
|
|
Stock-based
compensation
|
3,363
|
1,622
|
|
Adjusted
EBITDA
|
$
11,629
|
$
2,390
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
|
(in
thousands)
|
|
|
Free Cash Flow Data:
|
|
|
|
Net
cash provided by (used in) operating activities
|
$
6,909
|
$
(8,101
)
|
|
Purchase
of property and equipment
|
(1,830
)
|
(651
)
|
|
Purchase
of intangible assets
|
(241
)
|
(115
)
|
|
Free
cash flow
|
$
4,839
|
$
(8,867
)
|
|
|
Year
Ended December 31,
|
|||||
|
|
2018
|
2017
|
||||
|
|
Actual
(GAAP)
|
SBC
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC
|
Adjusted
(Non-GAAP)
|
|
|
(in thousands)
|
|||||
|
Adjusted Operating Income:
|
|
|
|
|
|
|
|
Revenue
|
$
74,643
|
$
-
|
$
74,643
|
$
36,506
|
$
-
|
$
36,506
|
|
Cost
of revenue
|
(40,194
)
|
(71
)
|
(40,123
)
|
(19,281
)
|
(21
)
|
(19,260
)
|
|
Gross
profit
|
34,449
|
(71
)
|
34,520
|
17,225
|
(21
)
|
17,246
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
Sales
and marketing
|
(9,611
)
|
(120
)
|
(9,491
)
|
(5,500
)
|
(53
)
|
(5,447
)
|
|
Research
and development
|
(10,380
)
|
(255
)
|
(10,125
)
|
(5,138
)
|
(50
)
|
(5,088
)
|
|
General
and administrative
|
(7,987
)
|
(2,917
)
|
(5,070
)
|
(5,887
)
|
(1,499
)
|
(4,388
)
|
|
Income
(loss) from operations
|
$
6,471
|
$
(3,363
)
|
$
9,834
|
$
700
|
$
(1,623
)
|
$
2,323
|
|
|
Year Ended December 31,
|
||
|
|
2018
|
|
2017
|
|
Risk-free interest rate
|
2.55%-2.96%
|
|
2.21%-2.22%
|
|
Expected volatility
|
39.14%-43.00%
|
|
28.62%-29.18%
|
|
Expected term (in years)
|
6.25
|
|
6.25
|
|
Expected dividend yield
|
0%
|
|
0%
|
|
|
Year Ended December 31,
|
||
|
|
2018
|
|
2017
|
|
Risk-free interest
rate
|
2.39%-2.94%
|
|
1.62%-2.43%
|
|
Expected
volatility
|
40.24%-45.48%
|
|
28.71% - 29.41%
|
|
Expected
term ( in years)
|
2.58-5.36
|
|
3.58-6.25
|
|
Expected
dividend yield
|
0%
|
|
0%
|
|
Grant Dates
|
Number of Common Shares Underlying Options Granted
|
Exercise Price per Common Share
|
Estimated Fair Value per Common Share
|
|
May
1, 2015
|
783,338
|
$
1.50
|
$
1.50
|
|
September
8, 2015
|
263,335
|
1.50
|
1.50
|
|
December
28, 2016
|
1,424,596
|
3.00
|
2.28
|
|
March
9, 2017
|
33,334
|
7.50
|
7.50
|
|
May
9, 2017
|
183,335
|
7.50
|
7.50
|
|
November
2, 2017
|
120,002
|
5.60
|
5.60
|
|
January
25, 2018
|
500,000
|
5.31
|
5.31
|
|
August
1, 2018
|
245,700
|
13.85
|
13.85
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
Revenue
|
100.0
%
|
100.0
%
|
|
Cost of revenue
|
53.8
|
52.8
|
|
Gross margin
|
46.2
|
47.2
|
|
Operating expenses:
|
|
|
|
Sales and marketing
|
12.9
|
15.1
|
|
Research and development
|
13.9
|
14.1
|
|
General and administrative
|
10.7
|
16.1
|
|
Total operating expenses, net
|
37.5
|
45.3
|
|
Income (loss) from operations
|
8.7
|
1.9
|
|
Interest expense, net
|
(0.6
)
|
(0.7
)
|
|
Other income (expense), net
|
1.7
|
(2.4
)
|
|
Equity
income in net income of affiliates
|
0.2
|
-
|
|
Income (loss) before income taxes
|
9.9
|
(1.1
)
|
|
Income tax expense
|
(1.1
)
|
(1.5
)
|
|
Net
income (loss)
|
8.8
|
(2.6
)
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
-
|
(1.5
)
|
|
Net
income( loss) attributable to ACM Research, Inc.
|
8.8
%
|
(1.1
)%
|
|
|
Year
Ended
December
31,
|
% Change
|
|
|
|
2018
|
2017
|
2018 v 2017
|
|
|
(in
thousands)
|
|
|
|
Revenue
|
$
74,643
|
$
36,506
|
104
%
|
|
|
Year
Ended
December
31,
|
% Change
|
|
|
|
2018
|
2017
|
2018 v 2017
|
|
|
(in
thousands)
|
|
|
|
Cost of
revenue
|
$
40,194
|
$
19,281
|
108
%
|
|
Gross
profit
|
$
34,449
|
$
17,225
|
100
|
|
Gross
margin
|
46.2
%
|
47.2
%
|
(1.0
)%
|
|
|
Year Ended
December
31,
|
% Change
|
|
|
|
2018
|
2017
|
2018 v 2017
|
|
|
(in
thousands)
|
|
|
|
Sales and marketing
expense
|
$
9,611
|
$
5,500
|
75
%
|
|
Research and
development expense
|
10,380
|
5,138
|
102
|
|
General and
administrative expense
|
7,987
|
5,887
|
36
|
|
Total operating
expenses, net
|
$
27,978
|
$
16,525
|
69
%
|
|
|
Year
Ended
December
31,
|
% Change
|
|
|
|
2018
|
2017
|
2018 v 2017
|
|
|
(in
thousands)
|
|
|
|
Interest expense,
net
|
$
(469
)
|
$
(268
)
|
75
%
|
|
Other income
(expense), net
|
1,255
|
(794
)
|
(258
)%
|
|
|
Year Ended
December 31,
|
|
|
|
2018
|
2017
|
|
|
(in
thousands)
|
|
|
Current:
|
|
|
|
U.S.
federal
|
$
-
|
$
-
|
|
U.S.
state
|
|
-
|
|
Foreign
|
(1,149
)
|
-
|
|
Total
current income tax expense
|
(1,149
)
|
-
|
|
Deferred:
|
|
|
|
U.S.
federal
|
-
|
-
|
|
U.S.
state
|
|
|
|
Foreign
|
343
|
(547
)
|
|
Total
deferred income (expense) benefit
|
343
|
(547
)
|
|
Total
current income tax expense
|
$
(806
)
|
$
(547
)
|
|
Lender
|
|
Agreement Date
|
|
Maturity Date
|
|
Annual Interest Rate
|
|
Maximum Borrowing Amount(1)
|
|
Amount Outstanding at December 31, 2018
|
|
|
|
|
|
|
|
|
|
(in thousands)
|
||
|
Bank of China Pudong Branch
|
|
August 2018
|
|
August 2019
|
|
5.22%
|
|
RMB30,000
|
|
RMB30,000
|
|
|
|
|
|
|
|
|
|
$4,372
|
|
$4,372
|
|
Bank of Shanghai Pudong Branch
|
|
February 2018
|
|
January 2019
|
|
5.15%
|
|
RMB50,000
|
|
RMB24,836
|
|
|
|
|
|
|
|
|
|
$7,800
|
|
$3,618
|
|
Shanghai
Rural Commercial Bank
|
|
January 2018
|
|
January
2019
|
|
5.44%
|
|
RMB10,000
|
|
RMB10,000
|
|
|
|
|
|
|
|
|
|
$1,457
|
|
$1,457
|
|
|
|
|
|
|
|
|
|
RMB90,000
|
|
RMB64,836
|
|
|
|
|
|
|
|
|
|
$13,629
|
|
$9,447
|
|
|
December
31,
2018
|
|
|
(in
thousands)
|
|
Cash
and cash equivalents
|
$
27,124
|
|
Accounts
receivable, less allowance for doubtful amounts
|
24,608
|
|
Inventory
|
38,764
|
|
Total
|
$
90,496
|
|
|
Page
|
|
Consolidated Financial Statements
|
63
|
|
|
|
|
Report of Independent Registered Public Accounting
Firm
|
64
|
|
|
|
|
Consolidated Balance Sheets as of December 31, 2018 and
2017
|
66
|
|
|
|
|
Consolidated Statements of Operations and Comprehensive Income
(Loss) for the Years ended December 31, 2018 and 2017
|
67
|
|
|
|
|
Consolidated Statements of Changes in Redeemable Convertible
Preferred Stock and Stockholders’ Equity (Deficit) for the
Years ended December 31, 2018 and 2017
|
68
|
|
|
|
|
Consolidated Statements of Cash Flows for the Years ended December
31, 2018 and 2017
|
69
|
|
|
|
|
Notes to Consolidated Financial Statements
|
70
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
|
(in thousands, except share and per share data)
|
|
|
Assets
|
|
|
|
Current
assets:
|
|
|
|
Cash
and cash equivalents
|
$
27,124
|
$
17,681
|
|
Accounts
receivable, less allowance for doubtful accounts of $0 and $0 as of
December 31, 2018 and 2017, respectively (note 3)
|
24,608
|
26,762
|
|
Other
receivables
|
3,547
|
2,491
|
|
Inventories
(note 4)
|
38,764
|
15,388
|
|
Prepaid
expenses
|
1,985
|
546
|
|
Other
current assets
|
-
|
46
|
|
Total
current assets
|
96,028
|
62,914
|
|
Property,
plant and equipment, net (note 5)
|
3,708
|
2,340
|
|
Intangible
assets, net
|
274
|
106
|
|
Deferred
tax assets (note 15)
|
1,637
|
1,294
|
|
Investment
in affiliates, equity method (note 10)
|
1,360
|
1,237
|
|
Other
long-term assets
|
40
|
-
|
|
Total
assets
|
103,047
|
67,891
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
Current
liabilities:
|
|
|
|
Short-term
borrowings (note 6)
|
9,447
|
5,095
|
|
Warrant
liability (note 8)
|
-
|
3,079
|
|
Accounts
payable
|
16,673
|
7,419
|
|
Advances
from customers
|
8,417
|
143
|
|
Income
taxes payable
|
1,193
|
44
|
|
Other
payables and accrued expenses (note 7)
|
10,410
|
6,037
|
|
Total
current liabilities
|
46,140
|
21,817
|
|
Other
long-term liabilities (note 9)
|
4,583
|
6,217
|
|
Total
liabilities
|
50,723
|
28,034
|
|
Commitments and contingencies (note 16)
|
|
|
|
Stockholders’
equity:
|
|
|
|
Common
stock – Class A, par value $0.0001: 100,000,000 shares
authorized as of December 31, 2018 and 2017. 14,110,315 shares
issued and outstanding as of December 31, 2018 and 12,935,546
shares issued and outstanding as of December 31, 2017 (note
13)
|
1
|
1
|
|
Common
stock–Class B, par value $0.0001: 7,303,533 shares authorized
as of December 31, 2018 and 2017. 1,898,423 shares issued and
outstanding as of December 31, 2018 and 2,409,738 shares issued and
outstanding as of December 31, 2017 (note 13)
|
-
|
-
|
|
Additional
paid in capital
|
56,567
|
49,695
|
|
Accumulated
deficit
|
(3,387
)
|
(9,961
)
|
|
Accumulated
other comprehensive income (loss)
|
(857
)
|
122
|
|
Total
stockholders’ equity
|
52,324
|
39,857
|
|
Total
liabilities and stockholders’ equity
|
$
103,047
|
$
67,891
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
|
( In thousands, except share and per share data)
|
|
|
Revenue
|
$
74,643
|
$
36,506
|
|
Cost of revenue
|
40,194
|
19,281
|
|
Gross profit
|
34,449
|
17,225
|
|
Operating expenses:
|
|
|
|
Sales and marketing
|
9,611
|
5,500
|
|
Research and development
|
10,380
|
5,138
|
|
General and administrative
|
7,987
|
5,887
|
|
Total operating expenses, net
|
27,978
|
16,525
|
|
Income from operations
|
6,471
|
700
|
|
Interest income
|
29
|
9
|
|
Interest expense
|
(498
)
|
(277
)
|
|
Other income
(expense), net
|
1,255
|
(794
)
|
|
Equity income in net income of affiliates
|
123
|
37
|
|
Income (Loss) before income taxes
|
7,380
|
(325
)
|
|
Income tax expense (note 15)
|
(806
)
|
(547
)
|
|
Net income (loss)
|
6,574
|
(872
)
|
|
Less: Net loss attributable to non-controlling interests
|
-
|
(554
)
|
|
Net income
(loss) attributable to ACM Research, Inc.
|
$
6,574
|
$
(318
)
|
|
Comprehensive income
(loss)
|
|
|
|
Net income
(loss)
|
6,574
|
(872
)
|
|
Foreign currency translation adjustment
|
(979
)
|
472
|
|
Comprehensive income (loss)
|
5,595
|
(400
)
|
|
Less: Comprehensive loss attributable to non-controlling interests
|
-
|
(369
)
|
|
Total comprehensive income
(loss) attributable to ACM Research, Inc. (note 2)
|
$
5,595
|
$
(31
)
|
|
|
|
|
|
Net income
(loss) attributable to ACM, Inc.
per common share (note 2):
|
|
|
|
Basic
|
$
0.42
|
(0.05
)
|
|
Diluted
|
$
0.37
|
$
(0.05
)
|
|
|
|
|
|
Weighted
average common shares outstanding used in computing
per share amounts (note 2):
|
|
|
|
Basic
|
15,788,460
|
6,865,390
|
|
Diluted
|
17,912,105
|
6,865,390
|
|
|
Redeemable Convertible Preferred Stock
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Series A
|
Series B
|
Series C
|
Series D
|
Series E
|
Series F
|
|
Common
Stock Class A
|
Common
Stock Class B
|
|
|
|
|
|
||||||||
|
|
shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Total Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional Paid-in
Capital
|
Accumulated Income (Deficit)
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Non-controlling
Interest
|
Total Stockholders’ Equity (Deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2016
|
385,000
|
$
288
|
1,572,000
|
$
1,572
|
1,360,962
|
$
2,041
|
1,326,642
|
$
4,975
|
—
|
$
—
|
3,663,254
|
$
9,158
|
$
18,034
|
2,228,740
|
$
1
|
2,409,738
|
$
1
|
$
7,620
|
$
(9,643
)
|
$
(413
)
|
$
4,919
|
$
2,485
|
|
Net
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(318
)
|
—
|
(554
)
|
(872
)
|
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
535
|
185
|
720
|
|
Exercise
of stock option
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
472,887
|
—
|
—
|
—
|
396
|
—
|
—
|
—
|
396
|
|
Stock-based
compensation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1,622
|
—
|
—
|
—
|
1,622
|
|
Purchase
of non-controlling interest
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(16,258
)
|
—
|
—
|
(4,550
)
|
(20,808
)
|
|
Issuance
of Series E Preferred Stock
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
4,998,508
|
$
5,800
|
—
|
—
|
5,800
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Issuance
of Common Stock to Ninebell
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
133,334
|
—
|
—
|
—
|
1,000
|
—
|
—
|
—
|
1,000
|
|
Issuance
of Common Stock to Shanghai and Pudong VC
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1,906,674
|
—
|
—
|
—
|
14,299
|
—
|
—
|
—
|
14,299
|
|
Convertible
preferred shares converted to common shares in connection with
initial public offering
|
(385,000
)
|
(288
)
|
(1,572,000
)
|
(1,572
)
|
(1,360,962
)
|
(2,041
)
|
(1,326,642
)
|
(4,975
)
|
(4,998,508
)
|
(5,800
)
|
(3,663,254
)
|
(9,158
)
|
(23,834
)
|
4,627,577
|
—
|
—
|
—
|
23,834
|
—
|
—
|
—
|
23,834
|
|
Proceeds
from initial public, net of capitalized IPO cost and issuance costs
of $2,791
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
3,566,334
|
—
|
—
|
—
|
17,181
|
—
|
—
|
—
|
17,181
|
|
Reclassification
of reverse split par value
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(1
)
|
1
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2017
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
$
-
|
12,935,546
|
$
1
|
2,409,738
|
$
-
|
$
49,695
|
$
(9,961
)
|
$
122
|
$
-
|
$
39,857
|
|
Net
income
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
6,574
|
—
|
—
|
6,574
|
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(979
)
|
—
|
(979
)
|
|
Exercise
of stock option
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
265,952
|
—
|
—
|
—
|
528
|
—
|
—
|
—
|
528
|
|
Stock-based
compensation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
3,363
|
—
|
—
|
—
|
3,363
|
|
Conversion
of class B common shares to Class A common shares
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
511,315
|
—
|
(511,315
)
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Exercise
of common stock warrant issued to SMC
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
397,502
|
—
|
—
|
—
|
2,981
|
—
|
—
|
—
|
2,981
|
|
Balance at December 31, 2018
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
-
|
$
-
|
$
-
|
14,110,315
|
$
1
|
1,898,423
|
$
-
|
$
56,567
|
$
(3,387
)
|
$
(857
)
|
$
-
|
$
52,324
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
|
(in thousands)
|
|
|
Cash flows from operating activities:
|
|
|
|
Net
income (loss)
|
$
6,574
|
$
(872
)
|
|
Adjustments
to reconcile net loss from operations to net cash provided by
operating activities
|
|
|
|
Depreciation
and amortization
|
417
|
271
|
|
Equity
income in net income of affiliates
|
(123
)
|
(37
)
|
|
Deferred
income taxes
|
(405
)
|
659
|
|
Stock-based
compensation
|
3,363
|
1,622
|
|
Loss
on disposals of fixed assets, intangible assets and other long-term
assets
|
-
|
1
|
|
Net
changes in operating assets and liabilities:
|
|
|
|
Accounts
receivable
|
883
|
(9,757
)
|
|
Other
receivables
|
(1,171
)
|
332
|
|
Inventory
|
(24,083
)
|
(3,073
)
|
|
Prepaid
expenses
|
(1,494
)
|
256
|
|
Other
current assets
|
44
|
8
|
|
Accounts
payable
|
9,825
|
1,905
|
|
Advances
from customers
|
8,316
|
(127
)
|
|
Income
tax payable
|
1,149
|
-
|
|
Other
payables and accrued expenses
|
4,954
|
1,789
|
|
Other
long-term liabilities
|
(1,340
)
|
(1,078
)
|
|
Net cash provided by (used in) operating activities
|
6,909
|
(8,101
)
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
Purchase
of property and equipment
|
(1,830
)
|
(651
)
|
|
Purchase
of intangible assets
|
(241
)
|
(115
)
|
|
Loan
to related party
|
-
|
(946
)
|
|
Purchase
of non-controlling interest
|
-
|
(20,808
)
|
|
Investments
in unconsolidated equity method affiliates
|
-
|
(1,200
)
|
|
Net cash used in investing activities
|
(2,071
)
|
(23,720
)
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
Proceeds
from short-term borrowings
|
17,726
|
11,154
|
|
Repayments
of short-term borrowings
|
(13,131
)
|
(11,110
)
|
|
Proceeds
from stock option exercise to common stock
|
528
|
396
|
|
Proceeds
from issuance of Series E convertible preferred stock
|
-
|
5,800
|
|
Proceeds
from issuance of common stock in connection with initial public
offering and concurrent private placement
|
-
|
18,717
|
|
Payment
of initial public offering expenses
|
-
|
(1,537
)
|
|
Investment
in affiliates
|
-
|
1,000
|
|
Proceeds
from issuance of common stock for non-controlling interest
purchase
|
-
|
14,300
|
|
Net cash provided by financing activities
|
5,123
|
38,720
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash
equivalent
|
$
(518
)
|
$
663
|
|
Net
increase in cash and cash equivalent
|
$
9,443
|
$
7,562
|
|
|
|
|
|
Cash
and cash equivalents at beginning of period
|
17,681
|
10,119
|
|
Cash and cash equivalents at end of period
|
$
27,124
|
$
17,681
|
|
|
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
Interest
paid
|
$
498
|
$
277
|
|
Non-cash financing activities:
|
|
|
|
Preferred
stock conversion to common stock in connection with initial public
offering
|
$
-
|
$
23,834
|
|
Warrant
conversion to common stock
|
$
3,079
|
-
|
|
Computer and office
equipment
|
3 to 5
years
|
|
Furniture and
fixtures
|
5
years
|
|
Leasehold
improvements
|
shorter of lease term or estimated
useful life
|
|
Manufacturing
equipment
|
for
small to medium-sized equipment, 5 years; for large
equipment,
estimated
by purchasing department at time of acceptance
|
|
Furniture
and fixtures
|
5
years
|
|
Transportation
equipment
|
4 to 5
years
|
|
Electronic
equipment
|
3
years
|
|
Leasehold
improvements
|
remaining
lease term for improvements on leased fixed assets or,
for
large improvements, estimated useful life;
not
less than 3 years for non-fixed asset repairs
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
Balance
at beginning of period
|
$
839
|
$
290
|
|
Additions
|
1,412
|
736
|
|
Utilized
|
(541
)
|
(187
)
|
|
Balance
at end of period
|
$
1,710
|
$
839
|
|
|
Year
Ended December 31
|
|
|
|
2018
|
2017
|
|
Customer
A
|
24.17
%
|
*
|
|
Customer
B
|
23.83
|
18.10
|
|
Customer
C
|
*
|
12.77
|
|
Customer
D
|
*
|
14.12
|
|
Customer
E
|
39.63
|
10.23
|
|
Consolidated balance sheets:
|
|
|
At
December 31, 2018
|
RMB
6.8634 to $1.00
|
|
At
December 31, 2017
|
RMB
6.5359 to $1.00
|
|
At
December 31, 2018
|
KRW
1,114.83 to $1.00
|
|
At
December 31, 2017
|
No
transactions in Korean Won
|
|
|
|
|
Consolidated statements of operations and comprehensive
income:
|
|
|
Year
ended December 31, 2018
|
RMB
6.6181 to $1.00
|
|
Year
ended December 31, 2017
|
RMB
6.7522 to $1.00
|
|
Year
ended December 31, 2018
|
KRW 1,100.11 to $1.00
|
|
Year
ended December 31, 2017
|
No
transactions in Korean Won
|
|
|
For the Year Ended
December 31
|
|
|
|
2018
|
2017
|
|
Numerator:
|
|
|
|
Net
income (loss)
|
$
6,574
|
$
(872
)
|
|
Net
loss attributable to non-controlling interest
|
-
|
(554
)
|
|
Net income (loss)
attributable to ACM, basic and diluted
|
6,574
|
$
(318
)
|
|
Denominator:
|
|
|
|
Weighted
average shares outstanding, basic
|
15,788,460
|
6,865,390
|
|
Effect
of dilutive securities
|
2,123,645
|
-
|
|
Weighted
average shares outstanding, diluted
|
17,912,105
|
6,865,390
|
|
Net
income (loss) attributable to ACM per common share:
|
|
|
|
Basic
|
$
0.42
|
$
(0.05
)
|
|
Diluted
|
$
0.37
|
$
(0.05
)
|
|
|
Year Ended December 31
|
|
|
|
2018
|
2017
|
|
Stock
options
|
3,715,779
|
3,372,292
|
|
Warrant
|
80,000
|
477,502
|
|
|
3,795,779
|
3,849,794
|
|
|
Fair Value Measurement at Reporting Date Using
|
|||
|
|
Quoted Prices in Active Markets for Identical Liabilities (Level
1)
|
Significant Other Observable Inputs (Level 2)
|
Significant Unobservable Inputs (Level 3)
|
Total
|
|
|
(in thousands)
|
|
||
|
As of December 31, 2018:
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
Short-term
borrowings
|
$
-
|
$
9,447
|
$
-
|
$
9,447
|
|
|
$
-
|
$
9,447
|
$
-
|
$
9,447
|
|
|
|
|
|
|
|
As of December 31, 2017:
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
Short-term
borrowings
|
$
-
|
$
5,095
|
$
-
|
$
5,095
|
|
Warrant
liability
|
-
|
-
|
3,079
|
3,079
|
|
|
$
-
|
$
5,095
|
$
3,079
|
$
8,174
|
|
|
December
31,
|
|
|
|
2018
|
2017
|
|
Accounts
receivable
|
$
24,608
|
$
26,762
|
|
Less:
Allowance for doubtful accounts
|
-
|
|
|
Total
|
$
24,608
|
$
26,762
|
|
|
December
31,
|
|
|
|
2018
|
2017
|
|
Raw
materials
|
$
12,646
|
$
6,181
|
|
Work
in process
|
9,631
|
4,328
|
|
Finished
goods
|
16,487
|
4,879
|
|
Total
inventory, gross
|
38,764
|
15,388
|
|
Inventory
reserve
|
-
|
-
|
|
Total
inventory, net
|
$
38,764
|
$
15,388
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
Manufacturing
equipment
|
$
9,703
|
$
9,660
|
|
Office
equipment
|
512
|
463
|
|
Transportation
equipment
|
184
|
203
|
|
Leasehold
improvement
|
1,379
|
277
|
|
Total
cost
|
11,778
|
10,603
|
|
Less:
Total accumulated depreciation
|
(8,102
)
|
(8,263
)
|
|
Construction
in progress
|
32
|
-
|
|
Total
property, plant and equipment, net
|
$
3,708
|
$
2,340
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
Line of credit up
to RMB 30,000 from Bank of China Pudong Branch, due on March 5,
2018 with annual interest rate of 5.69%, secured by certain of the
Company’s intellectual property and fully repaid on March 5,
2018 .
|
$
-
|
$
2,219
|
|
Line of credit up
to RMB 25,000 from Bank of Shanghai Pudong Branch, due on Various
dates of October 2018 with an annual interest rate of 5.66%,
guaranteed by the Company’s CEO and fully repaid on May 8,
2018.
|
-
|
2,111
|
|
Line of credit up
to RMB 50,000 from Bank of Shanghai Pudong Branch, due on April 17,
2019 with an annual interest rate of 4.99%, guaranteed by the
Company’s CEO.
|
3,133
|
-
|
|
Line of credit up
to RMB 50,000 from Bank of Shanghai Pudong Branch, due on February
14, 2019 with an annual interest rate of 5.15%, guaranteed by the
Company’s CEO.
|
485
|
-
|
|
Line of credit up
to RMB 5,000 from Shanghai Rural Commercial Bank, due on November
21, 2018 with an annual interest rate of 5.44%, guaranteed by the
Company’s CEO and pledged by accounts receivable (Note
3).
|
-
|
765
|
|
Line of credit up
to RMB 10,000 from Shanghai Rural Commercial Bank, due on January
23, 2019 with an annual interest rate of 5.44%, guaranteed by the
Company’s CEO and pledged by accounts receivable (Note
3).
|
1,457
|
-
|
|
Line of credit up
to RMB 30,000 from Bank of China Pudong Branch, due on June 6, 2019
with annual interest rate of 5.22%, secured by certain of the
Company’s intellectual property and the Company’s
CEO.
|
2,186
|
-
|
|
Line of credit up
to RMB 30,000 from Bank of China Pudong Branch, due on June 13,
2019 with annual interest rate of 5.22%, secured by certain of the
Company’s intellectual property and the Company’s
CEO.
|
2,186
|
|
|
Total
|
$
9,447
|
$
5,095
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
Lease
expenses and payable for leasehold improvement due to a related
party (note 11)
|
$
53
|
$
2,024
|
|
Accrued
commissions
|
2,931
|
836
|
|
Accrued
warranty
|
1,710
|
839
|
|
Accrued
payroll
|
626
|
745
|
|
Accrued
professional fees
|
64
|
60
|
|
Accrued
machine testing fees
|
3,076
|
684
|
|
Others
|
1,950
|
849
|
|
Total
|
$
10,410
|
$
6,037
|
|
|
December 31
|
|
|
|
2018
|
2017
|
|
Subsidies
to Stress Free Polishing project, commenced in 2008 and
2017
|
$
1,483
|
$
1,952
|
|
Subsidies
to Electro Copper Plating project, commenced in 2014
|
2,860
|
4,265
|
|
Subsidies
to Polytetrafluoroethylene, commenced in 2018
|
178
|
-
|
|
Other
|
62
|
-
|
|
Total
|
$
4,583
|
$
6,217
|
|
|
December 31,
2018
|
|
2019
|
$
1,391
|
|
2020
|
1,371
|
|
2021
|
1,403
|
|
2022
|
1,441
|
|
Total
|
$
5,606
|
|
|
Number
of Option Shares
|
Weighted
Average Grant Date Fair Value
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Term
|
|
Outstanding
at December 31, 2016
|
2,100,377
|
$
0.54
|
$
2.03
|
7.83
years
|
|
Granted
|
140,002
|
2.28
|
6.75
|
|
|
Exercised
|
(174,334
)
|
0.45
|
0.75
|
|
|
Expired
|
(3,752
)
|
0.54
|
3.00
|
|
|
Forfeited
|
(16,677
)
|
0.54
|
3.00
|
|
|
Outstanding
at December 31, 2017
|
2,045,616
|
0.66
|
2.46
|
7.57
years
|
|
Granted
|
745,700
|
1.52
|
8.12
|
|
|
Exercised
|
(151,650
)
|
0.53
|
2.06
|
|
|
Expired
|
(4,622
)
|
0.55
|
3.00
|
|
|
Forfeited
|
(131,639
)
|
0.97
|
3.87
|
|
|
Outstanding
at December 31, 2018
|
2,503,405
|
0.91
|
4.09
|
7.30
years
|
|
Vested
and exercisable at December 31, 2018
|
1,327,189
|
|
|
|
|
|
December 31,
|
||
|
|
2018
|
|
2017
|
|
Fair
value of common share(1)
|
$5.31-13.85
|
|
$5.60-7.59
|
|
Expected
term in years(2)
|
6.25
|
|
6.25
|
|
Volatility(3)
|
39.14% -43.00%
|
|
28.62% -29.18%
|
|
Risk-free
interest rate(4)
|
2.55%-2.96%
|
|
2.21%-2.22%
|
|
Expected
dividend(5)
|
0%
|
|
0%
|
|
|
Number of Option Shares
|
Weighted Average Grant Date Fair Value
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Term
|
|
Outstanding
at December 31, 2016
|
1,578,565
|
$
0.51
|
$
1.58
|
6.81
years
|
|
Granted
|
196,669
|
2.25
|
6.90
|
|
|
Exercised
|
(298,555
)
|
0.39
|
0.93
|
|
|
Expired
|
(133,336
)
|
0.45
|
0.75
|
|
|
Forfeited
|
(16,667
)
|
2.58
|
7.50
|
|
|
Outstanding
at December 31, 2017
|
1,326,676
|
0.78
|
2.52
|
7.54
years
|
|
Granted
|
-
|
-
|
-
|
-
|
|
Exercised
|
(114,302
)
|
0.43
|
1.92
|
-
|
|
Expired
|
-
|
-
|
-
|
-
|
|
Forfeited
|
-
|
-
|
-
|
-
|
|
Outstanding
at December 31, 2018
|
1,212,374
|
$
0.78
|
2.57
|
6.66 years
|
|
Vested
and exercisable at December 31, 2018
|
946,691
|
|
|
|
|
|
December 31,
|
||
|
|
2018
|
|
2017
|
|
Fair value of common share(1)
|
$10.88
|
|
$5.25-7.59
|
|
Expected term in years(2)
|
2.58-5.36
|
|
3.58-6.25
|
|
Volatility(3)
|
40.24%-45.48%
|
|
28.71-29.41 %
|
|
Risk-free interest rate(4)
|
2.39%-2.94%
|
|
1.62%-2.43 %
|
|
Expected dividend(5)
|
0%
|
|
0%
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
Current:
|
|
|
|
U.S.
federal
|
$
-
|
$
-
|
|
U.S.
state
|
-
|
-
|
|
Foreign
|
(1,149
)
|
-
|
|
Total
current tax expense
|
(1,149
)
|
-
|
|
Deferred:
|
|
|
|
U.S.
federal
|
-
|
-
|
|
U.S.
state
|
-
|
-
|
|
Foreign
|
343
|
(547
)
|
|
Total
deferred tax income (expense)
|
343
|
(547
)
|
|
Total
income tax expense
|
$
(806
)
|
$
(547
)
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
Deferred
tax assets:
|
|
|
|
Net
operating loss carry forwards (offshore)
|
$
16
|
$
4,418
|
|
Net
operating loss carry forwards (U.S.) and credit
|
4,105
|
683
|
|
Deferred
revenue (offshore)
|
558
|
656
|
|
Accruals
(U.S.)
|
11
|
18
|
|
Reserves
and other (offshore)
|
1,080
|
495
|
|
Stock-based
compensation (U.S.)
|
1,021
|
453
|
|
Property
and equipment (U.S.)
|
1
|
2
|
|
Total
gross deferred tax assets
|
6,792
|
6,725
|
|
Less:
valuation allowance
|
(5,155
)
|
(5,431
)
|
|
Total
deferred tax assets
|
1,637
|
1,294
|
|
Total
deferred tax liabilities
|
-
|
-
|
|
Translation
difference
|
-
|
-
|
|
Deferred
tax assets, net
|
$
1,637
|
$
1,294
|
|
|
Year Ended
December 31,
|
|
|
|
2018
|
2017
|
|
Effective
tax rate reconciliation:
|
|
|
|
Income
tax provision at statutory rate
|
21.00
%
|
34.00
%
|
|
State
taxes, net of Federal benefit
|
-
|
-
|
|
Foreign
rate differential
|
(20.88
)
|
6.80
|
|
Other
permanent difference
|
15.59
|
197.7
|
|
Effect
of tax reform
|
-
|
(757
)
|
|
Change
in valuation allowance
|
(4.78
)
|
349.9
|
|
Total
income tax expense (benefit)
|
(10.93
%)
|
(168.65
%)
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
Beginning
balance
|
$
44
|
$
44
|
|
Increase/(Decrease)
of unrecognized tax benefits taken in prior years
|
-
|
-
|
|
Increase/(Decrease)
of unrecognized tax benefits related to current year
|
-
|
-
|
|
Increase/(Decreases)
of unrecognized tax benefits related to settlements
|
-
|
-
|
|
Reductions
to unrecognized tax benefits related to lapsing statute of
limitations
|
-
|
-
|
|
Ending
balance
|
$
44
|
$
44
|
|
|
December 31,
|
|
|
|
2018
|
2017
|
|
Assets
|
|
|
|
Current
assets:
|
|
|
|
Cash
and cash equivalents
|
$
13,161
|
$
10,874
|
|
Accounts
Receivable
|
983
|
118
|
|
Inventory
|
720
|
565
|
|
Due
from intercompany
|
14,494
|
12,669
|
|
Other
receivable
|
175
|
50
|
|
Total
current assets
|
29,533
|
24,276
|
|
Investment
in unconsolidated subsidiaries
|
26,861
|
15,476
|
|
Due
from related party
|
-
|
946
|
|
Total
assets
|
56,394
|
40,698
|
|
Liabilities
and Stockholders’
Equity
|
|
|
|
Notes
payable
|
-
|
11
|
|
Accounts
payable
|
2,818
|
739
|
|
Other
payable
|
58
|
47
|
|
Income
taxes payable
|
1,193
|
44
|
|
Total
liabilities
|
4,069
|
841
|
|
Total
redeemable convertible preferred stocks
|
-
|
-
|
|
Total
stockholders’ equity
|
52,325
|
39,857
|
|
Total
liabilities and stockholders’ equity
|
$
56,394
|
$
40,698
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
Revenue
|
$
25,506
|
$
6,985
|
|
Cost
of revenue
|
(23,927
)
|
(6,394
)
|
|
Gross
profit
|
1,579
|
591
|
|
Operating
expenses:
|
|
|
|
Sales
and marketing expenses
|
(301
)
|
(368
)
|
|
General
and administrative expenses
|
(5,083
)
|
(3,961
)
|
|
Research
and development expenses
|
(255
)
|
(50
)
|
|
Loss
from operations
|
(4,060
)
|
(3,788
)
|
|
Equity
in earnings of unconsolidated subsidiaries
|
10,360
|
3,475
|
|
Other
income (expense), net
|
108
|
-
|
|
Interest
expense, net
|
166
|
(5
)
|
|
Income
(loss) before income taxes
|
6,574
|
(318
)
|
|
Income
tax expense (benefit)
|
-
|
-
|
|
Net
income (loss)
|
$
6,574
|
$
(318
)
|
|
|
Year Ended December 31,
|
|
|
|
2018
|
2017
|
|
Net
cash used in operating activities
|
$
(1,189
)
|
$
(13,848
)
|
|
Net
cash provided by (used in) investing activities
|
946
|
(21,754
)
|
|
Net
cash provided by financing activities
|
3,510
|
38,676
|
|
Net
increase in cash and cash equivalents
|
3,267
|
3,074
|
|
Cash
and cash equivalents, beginning of year
|
10,874
|
7,264
|
|
Effect
of exchange rate changes on cash and cash equivalents
|
(980
)
|
536
|
|
Cash
and cash equivalents, end of year
|
$
13,161
|
$
10,874
|
|
Exhibit No.
|
|
Description
|
|
|
Restated
Certificate of Incorporation of ACM Research, Inc.
|
|
|
|
Restated Bylaws of
ACM Research, Inc.
|
|
|
|
Form of
Warrant dated November 2, 2017 issued to the underwriters of ACM
Research, Inc.'s initial public offering exercisable for an
aggregate of 80,000 shares of Class A common stock
|
|
|
4.02
|
|
Senior
Secured Promissory Note dated March 30, 2018 issued by Shengxin
(Shanghai) Management Consulting Limited Partnership to ACM
Research (Shanghai), Inc.
|
|
4.03
|
|
Intercompany
Promissory Note dated March 30, 2018 issued by ACM Research
(Shanghai), Inc. to ACM Research, Inc.
|
|
|
Lease
dated March 22, 2017 between ACM Research, Inc. and D&J
Construction, Inc.
|
|
|
10.01(b)
|
|
Lease
Amendment dated February 28, 2018 between ACM Research, Inc. and
D&J Construction, Inc.
|
|
|
Lease
Amendment dated February 4, 2019 between ACM Research, Inc. and
D&J Construction, Inc.
|
|
|
10.02
|
|
Lease
Agreement dated April 26, 2018 between ACM Research (Shanghai),
Inc. and Shanghai Zhangjiang Group Co., Ltd.
|
|
10.03
|
|
Lease
Agreement dated January 18, 2018 between ACM Research (Shanghai),
Inc. and Shanghai Shengyu Culture Development Co.,
Ltd.
|
|
|
Securities Purchase
Agreement dated March 14, 2017 by and among ACM Research,
Inc., Shengxin (Shanghai) Management Consulting Limited Partnership
and ACM Research (Shanghai), Inc.
|
|
|
|
Securities Purchase
Agreement dated March 23, 2017 between ACM Research, Inc. and
Shanghai Science and Technology Venture Capital Co., Ltd., as
amended
|
|
|
|
Securities Purchase
Agreement dated August 31, 2017 by and among ACM Research, Inc.,
Shanghai Pudong High-Tech Investment Co., Ltd. and Pudong Science
and Technology (Cayman) Co., Ltd.
|
|
|
|
Securities Purchase
Agreement dated August 31, 2017 by and among ACM Research, Inc.,
Shanghai Zhangjiang Science & Technology Venture Capital Co.,
Ltd. and Zhangjiang AJ Company Limited
|
|
|
|
Ordinary Share
Purchase Agreement dated September 6, 2017 by and among
ACM Research, Inc., Ninebell Co., Ltd. and Moon-Soo
Choi
|
|
|
|
Class A Common
Stock Purchase Agreement dated September 6, 2017 by and among
ACM Research, Inc., Ninebell Co., Ltd. and Moon-Soo
Choi
|
|
|
|
Form of
Second Amended and Restated Registration Rights Agreement to be
entered into between ACM Research, Inc. and certain of its
stockholders
|
|
|
|
Stock
Purchase Agreement, dated October 11, 2017, by and among ACM
Research, Inc., Xunxin (Shanghai) Capital Co., Limited, Xinxin
(Hongkong) Capital Co., Limited and David H. Wang
|
|
|
|
Stock
Purchase Agreement, dated October 16, 2017, by and between ACM
Research, Inc. and Victorious Way Limited
|
|
|
|
Nomination and
Voting Agreement, dated October 11, 2017, by and among Xinxin
(Hongkong) Capital Co., Limited, ACM Research, Inc., David H. Wang,
and the individuals named therein
|
|
|
|
Voting
Agreement, dated March 23, 2017, by and among Shanghai Technology
Venture Capital Co., Ltd. (also known as Shanghai Science and
Technology Venture Capital Co., Ltd.) and ACM Research,
Inc.
|
|
|
|
2016
Omnibus Incentive Plan of ACM Research, Inc.
|
|
Exhibit No.
|
|
Description
|
|
|
Form of
Incentive Stock Option Grant Notice and Agreement under 2016
Omnibus Incentive Plan
|
|
|
|
Form of
Non-qualified Stock Option Grant Notice and Agreement under 2016
Omnibus Incentive Plan
|
|
|
|
Form of
Restricted Stock Unit Grant Notice and Agreement under 2016 Omnibus
Incentive Plan
|
|
|
|
Form of
Nonstatutory Stock Option Agreement of ACM Research,
Inc.
|
|
|
|
1998
Stock Option Plan of ACM Research, Inc.
|
|
|
|
Form of
Incentive Stock Option Agreement under 1998 Stock Option
Plan
|
|
|
|
Form of
Non-statutory Stock Option Agreement under 1998 Stock Option
Plan
|
|
|
|
Form of
Indemnification Agreement entered into between ACM Research, Inc.
and certain of its directors and officers
|
|
|
|
Executive Retention
Agreement dated November 14, 2016 between ACM Research, Inc.
and Min Xu
|
|
|
10.20+
|
|
Advisory Board
Agreement dated May 1, 2016 by and between ACM Research, Inc. and
Chenming Hu
|
|
10.21
|
|
Line of
Credit Agreement dated January 19, 2018 between ACM Research
(Shanghai), Inc. and Shanghai Rural Commercial Bank
|
|
10.22
|
|
Line of
Credit Agreement dated February 2, 2018 between ACM Research
(Shanghai), Inc. and Bank of Shanghai Pudong Branch
|
|
10.23
|
|
Line of
Credit Agreement dated August 24, 2018 between ACM Research
(Shanghai), Inc. and Bank of China Shanghai Pudong
Branch
|
|
10.24
|
|
Advisory Board
Agreement dated May 1, 2016 by and between ACM Research, Inc. and
Chenming Hu
|
|
10.25
|
|
Warrant
Exercise Agreement dated March 30, 2018 by and among ACM Research,
Inc., ACM Research (Shanghai), Inc., and Shengxin (Shanghai)
Management Consulting Limited Partnership
|
|
21.01
|
|
List of
Subsidiaries of ACM Research, Inc.
|
|
|
Consent
of BDO China Shu Lan Pan Certified Public Accountants
LLP
|
|
|
31.01
|
|
Certification of
Principal Executive Officer Pursuant to Rules 13a-14(a) and
15d-14(a) under the Securities Exchange Act of 1934, as Adopted
Pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
31.02
|
|
Certification of
Principal Financial Officer Pursuant to Rules 13a-14(a) and
15d-14(a) under the Securities Exchange Act of 1934, as Adopted
Pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
32.01
|
|
Certification of
Principal Executive Officer and Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
|
XBRL
Instance Document
|
|
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
|
ACM
RESEARCH, INC.
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
David H.
Wang
|
|
|
|
|
David H.
Wang
|
|
|
|
|
Chief Executive
Officer and President
|
|
|
Signature
|
|
Title
|
|
|
|
|
|
/s/ David H.
Wang
|
|
|
|
David H. Wang
|
|
Chief
Executive Officer, President and Director
(
Principal Executive
Officer
)
|
|
|
|
|
|
/s/ Lisa
Feng
|
|
|
|
Lisa Feng
|
|
Interim
Chief Financial Officer, Chief Accounting Officer and
Treasurer
(
Principal Accounting
Officer
)
|
|
|
|
|
|
/s/ Haiping
Dun
|
|
|
|
Haiping Dun
|
|
Director
|
|
|
|
|
|
/s/
Chenming Hu
|
|
|
|
Chenming Hu
|
|
Director
|
|
|
|
|
|
/s/
Tracy Liu
|
|
|
|
Tracy Liu
|
|
Director
|
|
|
|
|
|
/s/ Yinan
Xiang
|
|
|
|
Yinan Xiang
|
|
Director
|
|
|
|
|
|
/s/
Zhengfan Yang
|
|
|
|
Zhengfan
Yang
|
|
Director
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|